title: The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients.
abstract: Venous thromboembolism (VTE) acquired during hospitalization is common, yet preventable by the proper implementation of thromboprophylaxis which remains to be underutilized worldwide. As a result of an initiative by the Saudi Ministry of Health to improve medical practices in the country, an expert panel led by the Saudi Association for Venous Thrombo Embolism (SAVTE; a subsidiary of the Saudi Thoracic Society) with the methodological guidance of the McMaster University Guideline working group, produced this clinical practice guideline to assist healthcare providers in VTE prevention. The expert part panel issued ten recommendations addressing 10 prioritized questions in the following areas: thromboprophylaxis in acutely ill medical patients (Recommendations 1-5), thromboprophylaxis in critically ill medical patients (Recommendations 6-9), and thromboprophylaxis in chronically ill patients (Recommendation 10). The corresponding recommendations were generated following the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach.
authors.affiliation: Department of Intensive Care, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Kingdom of Saudi Arabia. E-mail. fahadalhameed@hotmail.com.
authors.forename: Fahad M
authors.initials: FM
authors.lastname: Al-Hameed
authors.forename: Hasan M
authors.initials: HM
authors.lastname: Al-Dorzi
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Abdelaal
authors.forename: Ali
authors.initials: A
authors.lastname: Alaklabi
authors.forename: Ebtisam
authors.initials: E
authors.lastname: Bakhsh
authors.forename: Yousef A
authors.initials: YA
authors.lastname: Alomi
authors.forename: Mohammad
authors.initials: M
authors.lastname: Al Baik
authors.forename: Salah
authors.initials: S
authors.lastname: Aldahan
authors.forename: Holger
authors.initials: H
authors.lastname: Schünemann
authors.forename: Jan
authors.initials: J
authors.lastname: Brozek
authors.forename: Wojtek
authors.initials: W
authors.lastname: Wiercioch
authors.forename: Andrea J
authors.initials: AJ
authors.lastname: Darzi
authors.forename: Reem
authors.initials: R
authors.lastname: Waziry
authors.forename: Elie A
authors.initials: EA
authors.lastname: Akl
mesh_terms: D006801:Humans; D000925:Anticoagulants / Q000627:therapeutic use; D016638:Critical Illness; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D006493:Heparin / Q000627:therapeutic use; D012307:Risk Factors; D012529:Saudi Arabia; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006493:Heparin